Xiao-yan Ding
Beijing, 100015, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
CRAFITY score and nomogram predict the clinical efficacy of lenvatinib combined with immune checkpoint inhibitors in hepatocellular carcinoma.
Journal: World journal of gastroenterology
Published: September 23, 2024
Transcatheter arterial chemoembolization combined with PD-1 inhibitors and Lenvatinib for hepatocellular carcinoma with portal vein tumor thrombus.
Journal: World journal of gastroenterology
Published: September 27, 2023
Clinicopathological Features of Hepatocellular Carcinoma with Metabolic Risk Factors.
Journal: Journal of hepatocellular carcinoma
Published: April 04, 2023
Blockade of the Dopamine D3 Receptor Attenuates Opioids-Induced Addictive Behaviours Associated with Inhibiting the Mesolimbic Dopamine System.
Journal: Neuroscience bulletin
Published: September 13, 2022
CT-guided percutaneous chemical ablation combined with radiofrequency ablation for hepatocellular carcinomas in high-risk locations: lobaplatin vs. ethanol.
Journal: American journal of translational research
Published: March 21, 2022
Differences in Liver Injury and Trophoblastic Mitochondrial Damage in Different Preeclampsia-like Mouse Models.
Journal: Chinese medical journal
Published: June 12, 2015
Prognostic factors and analyses of different therapeutic strategies in HR+ breast cancer patients with bone-only metastases
Journal: Zhonghua yi xue za zhi
Published: January 19, 2013
Showing 1-8 of 8
Last Updated: 09/26/2026